News und Analysen
EQS-News: JOST grows strongly in all regions despite challenging market conditions
EQS-News: Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
EQS-News: Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
EQS-News: Energiekontor AG: Energiekontor with strong operational momentum in the first nine months of 2025 – project progress confirms strong basis for continued growth
EQS-News: Stable earnings despite portfolio adjustment - 2025 guidance confirmed, strong growth in branded pharmaceuticals
EQS-News: Verbio SE: Solid start in Q1 2025/26; forecast for 2025/26 confirmed
EQS-News: Verbio SE: Solid start in Q1 2025/26; forecast for 2025/26 confirmed
EQS-News: secunet Security Networks AG continues growth journey in the first nine months of 2025 – outlook for 2025 confirmed and specified
EQS-News: PVA TePla: Order intake up significantly in the third quarter, revenue and earnings impacted by project delays
EQS-News: HelloFresh Rejects Misleading Allegations in Grizzly Research Report
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every
EQS-News: HelloFresh rejects accusations by Grizzly Research
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from
EQS-Adhoc: HOCHTIEF Aktiengesellschaft: HOCHTIEF increases operational net profit guidance for 2025
EQS-News: Energiekontor AG: Financial close for three more wind park projects – construction activity at a record high
EQS-News: 9-month results 2025: Basler AG confirms strong growth in sales and earnings
EQS-Adhoc: Basler AG: Basler AG announces change in its Management Board
EQS-News: Scout24 delivers strong Q3 2025; full-year guidance narrowed towards upper end
EQS-News: Knorr-Bremse fully on track: Strong rail business and further improvement in profitability
EQS-News: Befesa delivers strong Q3 2025 results with adjusted EBITDA up 27% and net income up 318%
EQS-News: HelloFresh SE Delivers Robust Efficiency Gains and Strong YTD Cash Flow in Q3 2025; Accelerates Product Investment Strategy